The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

Chime Biologics, a global CDMO, and Mabgeek, a clinical-stage innovative antibody drug development biotech, have successfully ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, has appointed Lori ...

Veeda Group has unveiled a new logo and brand identity— Veeda Lifesciences —reflecting the brand’s evolution from a ...

Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.

Sangamo plans to explore all options to commercialize the Hemophilia A asset.

Becomes the first subcutaneously administered PD-1 inhibitor.

Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers. As use of outsourcing increases, more companies see it as strategic, and relationships with service ...

Amgen is investing $1 billion to establish a second drug substance manufacturing facility in North Carolina. This brings the company’s total planned investment in Holly Springs to more than $1.5 ...

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Gilead Sciences Inc.’s Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with ...